3Palazzuoli A,Deckers J,Calabro A,et al.Brain natriuretic peptide and other risk markers for outcome assessment in patients with non-ST-elevation coronary syndromes and preserved systolic function[J].Am J Cardiol,2006,28(10):322-328.
4European Society of Cardiology.Guidelines for the diagnosis and treatment of chronic heart failure[J].Eur Heart J,2001,22:1527-1560.
5Pearson TA,Mensah GA,Alexander RW,et al.Markers of inflammation and cardiovascular disease:application to clinical and public health practice:statement for health care professionals from the Centers for Disease Control and Prevention and the American Heart Association[J].Circulation,2003,107(3):499-511.
6Koenig W,Khuseyinova N.Biomarkers of at herosclerotic plaque instability and rupture[J].Arterioscler Thromb Vasc Biol,2007,27(1):15-26.
7Ridker PM,Rifai N,Rose L,et al.Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events[J].N Eng J Med,2002,347(20):1557-1565.
8Al-Obaidi MK,Stubbs PJ,Amesery R,et al.Acute and convalescent changes in plasma homocysteine concentration in acute coronary syndrome[J].Heart,2001,85(4):380-384.
